PGNY earnings
Progyny Inc. (PGNY) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- Progyny, Inc. Announces First Quarter 2026 ResultsReports Record First Quarter Revenue of $328.5 MillionEarly Selling Season Activity Reflects Robust Demand for Women's Health and Family Building SolutionsReturned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended March 31, 2026 ("the first quarter of 2026"), as compared to the three-month period ended March 31, 2025 ("the first quarter of 2025" or "the prior year period"). "We're pleased with the strong start to the ye
- Progyny, Inc. Announces Details for Its First Quarter 2026 Results ReportNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode. An
- Progyny, Inc. Announces Fourth Quarter 2025 ResultsReports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced its financial results for the three- and twelve-month periods ended December 31, 2025 ("the fourth quarter of 2025" and "the full year", resp
- Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results ReportNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using t
- Progyny, Inc. Announces Third Quarter 2025 ResultsReports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing BaseRecord $156.0 Million in Operating Cash Flow Generated over the First Nine Months of 2025Board Authorizes Up to $200 Million in Share Repurchase Program NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended September 30, 2025 ("the third quarter of 2025"), as compared to the th
- Progyny, Inc. Announces Details for Its Third Quarter 2025 Results ReportNEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcod
- Progyny, Inc. Announces Second Quarter 2025 ResultsReports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member Engagement NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended June 30, 2025 ("the second quarter of 2025") as compared to the three-month period ended June 30, 2024 ("the second quarter of 2024" or "the prior year period"). "The strong second quarter results
- Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results ReportOperational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced that it has entered into a revolving credit facility (the "revolver" or the "facility") which makes available to the Company up to $200 million in aggregate revolving credit commitments, which the Company can utilize for revolving credit borrowings, subject to customary borrowing conditions, until maturity on July 1, 2030. The facility is expe
- Progyny, Inc. Announces First Quarter 2025 ResultsReports Record Revenue of $324.0 Million, Reflecting 16.5% GrowthRaises Full Year Guidance Due to Strong Start to the YearEarly Selling Season Activity Reflects Ongoing Demand in Women's Health and Family Building Solutions NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended March 31, 2025 ("the first quarter of 2025") as compared to the three-month period ended March 31, 2024 ("the first quarter of 2024" or "the prior year period"). "We're pleased with the strong start to the year, highlighted by both our
- Progyny, Inc. Announces Details for Its First Quarter 2025 Results ReportNEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode. An audio repl
- Progyny, Inc. Announces Fourth Quarter 2024 ResultsReports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three- and twelve-month periods ended December 31, 2024 ("the fourth quarter of 2024" and "the full year", respectively) as compared to the three- and twelve-month periods ended December 31, 2023 ("the fourth quarter of 2023" and "the prior year period",
- Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results ReportNEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.41
- Progyny, Inc. Announces Third Quarter 2024 ResultsSales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest Services in Maternity and/or Menopause Programs in 2025 NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three-month period ended September 30, 2024 ("the third quarter of 2024") as compared to the three-month period ended September 30, 2023 ("the third quarter of 2023" or "the prior year period"). "The utilization r
- Progyny, Inc. Announces Details for Its Third Quarter 2024 Results ReportNEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended September 30, 2024 after the close of the market on Tuesday, November 12, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and usin
- Progyny, Inc. Announces Second Quarter 2024 ResultsAchieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three-month period ended June 30, 2024 ("the second quarter of 2024") as compared to the three-month period ended June 30, 2023 ("the second quarter of 2023" or "the prior year period"). "The rate of utilization in the second quarter was consistent with our expectations, indicating that the demand for treatment remains both healt
- Progyny, Inc. Announces Details for Its Second Quarter 2024 Results ReportNEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the sa
- Progyny, Inc. Announces First Quarter 2024 ResultsNEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three-month period ended March 31, 2024 ("the first quarter of 2024") as compared to the three-month period ended March 31, 2023 ("the first quarter of 2023" or "the prior year period"). "Utilization through the end of February was consistent with the record engagement we saw a year ago. However, March was modestly below our expectations, coinciding with the national conversations concerning fertility treatments and access to maternal healthcare following the Alab
- Progyny, Inc. Announces Details for Its First Quarter 2024 Results ReportNEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended March 31, 2024 after the close of the market on Thursday, May 9, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the sa
- Progyny, Inc. Announces Fourth Quarter 2023 ResultsReports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three- and twelve-month periods ended December 31, 2023 ("the fourth quarter of 2023" and "the full year", respectively) as compared to the three- and twelve-month periods December 31, 2022 ("the fourth quarter of 2022" and "the prior year perio
- Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results ReportNEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2023 after the close of the market on Tuesday, February 27, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.
- Progyny, Inc. Announces Third Quarter 2023 ResultsRecord Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30, 2023 ("the third quarter of 2023") as compared to the three-month period ended September 30, 2022 ("the third quarter of 2022" or "the prior year period"). "We're pleased with our third quarter financ
- Progyny, Inc. Announces Details for Its Third Quarter 2023 Results ReportNEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2023 after the close of the market on Tuesday, November 7, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.9
- Progyny, Inc. Announces Second Quarter 2023 ResultsReports Record Quarterly Revenue of $279.4 Million, Reflecting 43% Growth Over the Prior Year PeriodAchieves Record Quarterly Operating Cash Flow of $76.0 MillionRaises Full Year Revenue and Earnings GuidanceContinuing to See Strong Employer Demand for Fertility and Family Building Solutions NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended June 30, 2023 ("the second quarter of 2023") as compared to the three-month period ended June 30, 2022 ("the second quarter of
- Progyny, Inc. Announces Details for Its Second Quarter 2023 Results ReportNEW YORK, July 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2023 after the close of the market on Thursday, August 3, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413
- Progyny, Inc. Announces First Quarter 2023 ResultsReports Record Quarterly Revenue of $258.4 Million, Reflecting 50% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Demand Continues for Family Building Solutions as Affirmed by Healthy Utilization, Early Sales Activity and New Partnerships NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended March 31, 2023 ("the first quarter of 2023") as compared to the three-month period ended March 31, 2022 ("the first quarter of 2022" or "the pr
- Progyny, Inc. Announces Details for Its First Quarter 2023 Results ReportNEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended March 31, 2023 after the close of the market on Monday, May 8, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.61
- Progyny, Inc. Announces Fourth Quarter 2022 ResultsReports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance for 2023, Anticipates Crossing $1 Billion Revenue Milestone NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three- and twelve-month periods ended December 31, 2022 ("the fourth quarter of 2022" and "the full year", respectively) as compared to the three- and twelve-month periods ended December
- Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results ReportNEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period and full year ended December 31, 2022 after the close of the market on Monday, February 27, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call b
- Progyny, Inc. Announces Third Quarter 2022 ResultsReceives Record Number of New Client Commitments in Selling SeasonReports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year PeriodRaises Full Year 2022 Guidance, Reflecting Fourth Quarter Revenue Growth of 59% to 67% NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended September 30, 2022 ("the third quarter of 2022") as compared to the three-month period ended September 30, 2021 ("the third quarter of 2021" or "the prior year period"
- Progyny, Inc. Announces Details for Its Third Quarter 2022 Results ReportNEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2022 after the close of the market on Thursday, November 3, 2022. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.
- Progyny, Inc. Announces Second Quarter 2022 ResultsReports Record Quarterly Revenue of $195.0 Million, Reflecting 52% Growth Over the Prior Year PeriodSeeing Strong Employer Demand for Fertility and Family Building Benefit SolutionsRaises Lower End of Full Year 2022 Guidance RangesIssues Revenue Guidance of $190.0 to $197.0 Million for the Third Quarter, Reflecting Growth of 55% to 61% NEW YORK, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY) ("Progyny" or the "Company"), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its financial results for the three-month period ended June 30, 2022 ("the second quarter of 2022") as compared to the three-month peri
- Progyny, Inc. Announces Details for Its Second Quarter 2022 Results ReportNEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2022 after the close of the market on Thursday, August 4, 2022. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413
- Progyny, Inc. Announces Details for Its First Quarter 2022 Results ReportNEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2022 after the close of the market on Thursday, May 5, 2022. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call
- Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2021 Results ReportNEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31, 2021 after the close of the market on Monday, February 28, 2022. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants
- Progyny, Inc. Announces Details for Its Third Quarter 2021 Results ReportNEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended September 30, 2021 after the close of the market on Thursday, November 4, 2021. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access t
- Progyny, Inc. Announces Details for Its Second Quarter 2021 Results ReportNEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended June 30, 2021 after the close of the market on Thursday, August 5, 2021. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call